grapiprant (Galliprant)

From Aaushi

Jump to navigation Jump to search

^[1]

Indications

treatment of osteoarthritis in dogs

Dosage

tablets 20 mg

Mechanism of action

PGE2 receptor antagonist

More general terms

non-steroidal anti-inflammatory agent (NSAID)

References

↑ FDA Animal & Veterinary. March 21, 2016 FDA Approves Galliprant, a New Animal Drug for Osteoarthritis in Dogs. http://www.fda.gov/AnimalVeterinary/NewsEvents/CVMUpdates/ucm491552.htm

Database

PubChem: http://pubchem.ncbi.nlm.nih.gov/summary/summary.cgi?cid=11677589

Retrieved from "https://aaushi.info/w/index.php?title=A487910&oldid=1131719"

↑ Back to top